Résultats de la recherche - Ge, Hangping
- Résultat(s) 1 - 9 résultats de 9
-
1
-
2
-
3
First Report of Severe Autoimmune Hemolytic Anemia During Eltrombopag Therapy in Waldenström Macroglobulinemia-Associated Thrombocytopenia par Shen, Yingying, Yu, Fanhua, Ge, Hangping, Shao, Keding, Zhou, Yuhong, Ye, Baodong, Shen, Yiping, Wu, Dijiong
Publié 2021Texte -
4
Coexistence of thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an Asian woman: a case report par Ge, Hangping, Shi, Zhan, Zheng, Zhiyin, Zhu, Qiuping, Hong, Lili, Zhang, Yu, Shen, Jianping, Deng, Shu
Publié 2022Texte -
5
Resibufogenin inhibits the malignant characteristics of multiple myeloma cells by blocking the PI3K/Akt signaling pathway par Zhou, Yan, Hong, Zirui, Jin, Keting, Lin, Chenjun, Xiang, Jingjing, Ge, Hangping, Zheng, Zhiyin, Shen, Jianping, Deng, Shu
Publié 2022Texte -
6
The Combination of Jiedu Xiaoluo Decoction with Autologous Peripheral Blood Stem Cell Transplantation (APBSCT) Accelerates Disease Remission of Non-Hodgkin Lymphoma par Zhang, Yu, Xiang, Jingjing, Zhu, Ni, Ge, Hangping, Sheng, Xianfu, Deng, Shu, Chen, Junfa, Yu, Lihong, Zhou, Yan, Shen, Jianping
Publié 2021Texte -
7
Curcumin in combination with homoharringtonine suppresses lymphoma cell growth by inhibiting the TGF-β/Smad3 signaling pathway par Zhang, Yu, Xiang, Jingjing, Zhu, Ni, Ge, Hangping, Sheng, Xianfu, Deng, Shu, Chen, Junfa, Yu, Lihong, Zhou, Yan, Shen, Jianping
Publié 2021Texte -
8
Curcumin in Combination With Omacetaxine Suppress Lymphoma Cell Growth, Migration, Invasion, and Angiogenesis via Inhibition of VEGF/Akt Signaling Pathway par Zhang, Yu, Xiang, Jingjing, Zhu, Ni, Ge, Hangping, Sheng, Xianfu, Deng, Shu, Chen, Junfa, Yu, Lihong, Zhou, Yan, Shen, Jianping
Publié 2021Texte -
9
Correction for: Curcumin in combination with homoharringtonine suppresses lymphoma cell growth by inhibiting the TGF-β/Smad3 signaling pathway par Zhang, Yu, Xiang, Jingjing, Zhu, Ni, Ge, Hangping, Sheng, Xianfu, Deng, Shu, Chen, Junfa, Yu, Lihong, Zhou, Yan, Shen, Jianping
Publié 2022Texte